Elucida Oncology to hold USD 50–100m Series B in early 2022 for clinical development, in active partnership discussions for platform tech, says CEO Feb 11, 2021
A longtime Pfizer chief's ultra-quiet biotech re-emerges with new cash and plans for the clinic Jan 13, 2021
